Myths and Facts about Vitiligo: An Epidemiological Study

Area of Science:

• Dermatology
• Pharmacology
• Patient Adherence Research

Background:

• Vitiligo is a complex pigmentary disorder often requiring multiple medications, complicating treatment.
• The stigmatized nature of vitiligo leads patients to seek unproven therapies, worsening outcomes.
• Poor treatment adherence in vitiligo is often misinterpreted as lack of therapeutic response, eroding patient trust.

Purpose of the Study:

• To assess patient compliance in vitiligo treatment.
• To identify factors influencing medication adherence and non-adherence.
• To monitor adverse effects and drug interactions associated with vitiligo therapies.

Main Methods:

• A one-year study conducted at the Institute of Applied Dermatology.
• Patient compliance assessed using the Morisky Medication Adherence Scale.
• Adverse reactions and drug interactions evaluated using Naranjo and drug interaction probability scales.

Main Results:

• 71% of vitiligo patients exhibited low medication adherence.
• Key adherence factors include family support, physician trust, education, and perceived effectiveness.
• Non-adherence drivers encompass forgetfulness, feasibility issues, polypharmacy, and treatment duration.

Conclusions:

• Significant hurdles exist in delivering safe and effective vitiligo treatment.
• Addressing patient adherence is critical for improving therapeutic outcomes in vitiligo.
• Further research is needed, challenging the belief that vitiligo is incurable.